Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| phosphorus oxoanion | CHEBI_33461 | |
| polyphosphoric acid | CHEBI_52641 | [A polymerized phosphorus oxoacid of general formula HO[PO2OH]nH formed by condensation of orthophosphoric acid molecules and containing a backbone chain consisting of alternating P and O atoms covalently bonded together.] |
| CHEBI_5974 | CHEBI_5974 | |
| 8-[2-[(2-chlorophenyl)methylidene]hydrazinyl]-8-oxooctanoic acid methyl ester | CHEBI_125243 | |
| CHEBI_16839 | CHEBI_16839 | |
| iron chelate | CHEBI_5975 | |
| iron coordination entity | CHEBI_33892 | |
| 2-[3-[(3S,3'S,4'R,6'S,8'R,8'aR)-8'-[1-azocanyl(oxo)methyl]-6'-(4-hydroxyphenyl)-1',2-dioxo-3',4'-diphenyl-5-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]yl]prop-2-ynyl]propanedioic acid dimethyl ester | CHEBI_125244 | |
| CHEBI_5976 | CHEBI_5976 | |
| (3S,3'S,4'R,6'S,8'R,8'aR)-6'-[4-[2-[[(3S,6R,7S,8aS)-6-(4-hydroxyphenyl)-3-(2-methylpropyl)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-7-yl]-oxomethoxy]ethoxy]phenyl]-1',2-dioxo-3',4'-diphenyl-8'-spiro[1H-indole-3,7'-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxylic acid prop-2-enyl ester | CHEBI_125245 | |
| 4-[[(4-acetyl-2,3-dihydro-1,4-benzoxazin-7-yl)sulfonylamino]methyl]-N-(3-methylphenyl)-1-cyclohexanecarboxamide | CHEBI_125246 | |
| DG(22:1(13Z)/16:0/0:0) | CHEBI_89834 | |
| irilone | CHEBI_5970 | [A hydroxyisoflavone that is 6,7-methylenedioxyisoflavone substituted by hydroxy groups at positions 5 and 4'.] |
| immunomodulator | CHEBI_50846 | [Biologically active substance whose activity affects or plays a role in the functioning of the immune system.] |
| LSM-36717 | CHEBI_125247 | |
| 1-Mercapto-2-propanone | CHEBI_89835 | |
| irinotecan hydrochloride (anhydrous) | CHEBI_5971 | [A hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of its trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. It is converted via hydrolysis of the carbamate linkage to its active metabolite, SN-38, which is ~1000 times more active.] |
| irinotecan(1+) | CHEBI_90895 | [An organic cation obtained by protonation of the tertiary amino group of irinotecan.] |
| EC 5.99.1.2 (DNA topoisomerase) inhibitor | CHEBI_50276 | [A topoisomerase inhibitor that inhibits the bacterial enzymes of the DNA topoisomerases, Type I class (EC 5.99.1.2) that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. These bacterial enzymes reduce the topological stress in the DNA structure by relaxing negatively, but not positively, supercoiled DNA.] |
| (6S,7R,8aR)-N-[6-(dimethylamino)hexyl]-6-[3-(2-hydroxyethoxy)phenyl]-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-7-carboxamide | CHEBI_125248 |